Doxorubicin-loaded mesoporous magnetic nanoparticles to induce apoptosis in breast cancer cells

Biomedicine and Pharmacotherapy

Volumn 69, Issue , 2015, Pages 355-360

  Zou, Yan ^a,b   Liu, Pin ^b   Liu, Chuan He ^c   Zhi, Xu Ting ^d  

^a SHANDONG UNIVERSITY   (China)

^b Heze University   (China)

^c Department of Orthopaedics Dingtao County Hospital   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Anticancer effect; Breast cancer; Doxorubicin; Magnetic nanoparticles; Thermotherapy

Indexed keywords

CHITOSAN COATED MESOPOROUS MAGNETIC NANOPARTICLE; CHITOSAN NANOPARTICLE; DOXORUBICIN; MAGNETIC NANOPARTICLE; MESOPOROUS MAGNETIC NANOPARTICLE; NANOCARRIER; NANOSIZED MAGNETIC NANOPARTICLE; UNCLASSIFIED DRUG; BIOMATERIAL; CHITOSAN; MAGNETITE NANOPARTICLE;

ALTERNATING CURRENT MAGNETIC FIELD; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL ADHESION; CELL DEATH; CELL KILLING; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; HEAT TREATMENT; HYPERTHERMIC THERAPY; IN VITRO STUDY; MAGNETIC FIELD; MCF 7 CELL LINE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; BREAST TUMOR; CELL SHAPE; CHEMISTRY; DRUG EFFECTS; FEMALE; HUMAN; LIGHT; PARTICLE SIZE; PATHOLOGY; POROSITY; RADIATION SCATTERING;

APOPTOSIS; BIOCOMPATIBLE MATERIALS; BREAST NEOPLASMS; CELL SHAPE; CHITOSAN; DOXORUBICIN; FEMALE; HUMANS; LIGHT; MAGNETIC FIELDS; MAGNETITE NANOPARTICLES; MCF-7 CELLS; PARTICLE SIZE; POROSITY; SCATTERING, RADIATION;

EID: 84922229613     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.12.012     Document Type: Article

References (21)

1. Eccles S.A., Aboagye E.O., Ali S., Anderson A.S., Armes J., Berditchevski F., et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 2013, 15:R92.
2. World Health Organization.International Agency for Research on Cancer (IARC) GLOBOCAN 2012: estimated incidence, mortality and prevalence worldwide in 2012 2014, February, Available from: http://globocan.iarc.fr (under Fact Sheets, choose "Breast" and "World").
3. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
4. Van Vlerken L.E., Amiji M.M. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv 2006, 3:205-216.
5. Cho K., Wang X., Nie S., Chen Z.G., Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008, 14:1310-1316.
6. Miyata K., Christie R.J., Kataoka K. Polymeric micelles for nano-scale drug delivery. React Funct Polym 2011, 71:227.
7. Ruttala H.B., Ko Y.T. Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy. Pharm Res 2014, 10.1007/s11095-014-1512-2.
8. Rongran W., Cheng L., Zheng M., Cheng R., Meng F., Deng C., et al. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release. Biomacromolecules 2012, 13:2429.
9. Lian H.Y., Hu M., Liu C.H., Yamauchi Y., Wu K.C.W. Highly biocompatible, hollow coordination polymer nanoparticles as cisplatin carriers for efficient intracellular drug delivery. Chem Commun 2012, 48:515-5153.
10. Hamman J.H. Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. Mar Drugs 2010, 8:1305-1322.
11. Arulmozhi V., Pandian K., Mirunalini S. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerfaces 2013, 110:313-320.
12. Javid A., Ahmadian S., Saboury A.A., Kalantar S.M., Rezaei-Zarchi S. Chitosan coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells. Chem Biol Drug Des 2013, 82:296-306.
13. McBain S.C., Yiu H.H.P., Dobson J. Magnetic nanoparticles for gene and drug delivery. Int J Nanomed 2008, 3:169-180.
14. Andrade F., Antunes F., da Silva A.N.S., das Neves J., Ferreira D., Sarmento B. Chitosan formulations as carriers for therapeutic proteins. Curr Drug Discov Technol 2011, 8:157-172.
15. Dash M., Chiellini F., Ottenbrite R.M., Chiellini E. Chitosan: a versatile semisynthetic polymer in biomedical applications. Prog Polym Sci 2011, 36:981-1014.
16. Longhi A., Ferrari S., Bacci G., Specchia S. Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma. Anticancer Drugs 2007, 18:737-744.
17. Tan M.L., Choong P.F.M., Dass C.R. Review: doxorubicin delivery systems based on chitosan for cancer therapy. J Pharm Pharmacol 2009, 61:131-142.
18. Lamprecht A., Schafer U., Lehr C.M. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res 2001, 18:788-793.
19. Fu W., Yang H., Bala H., Liu S., Li M., Zou G. Preparation and characteristics of core-shell structure cobalt/silica nanoparticles. Mater Chem Phys 2006, 100:246.
20. Veiseh O., Gunn J., Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010, 62:284-304.
21. Lee J.H., Jang J.T., Choi J.S., Moon S.H., Noh S.H., Kim J.W., et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol 2011, 6:418-422.